Assessment and Treatment of Dupuytren's Contracture
Dupuytren's contracture should be treated with a combination of non-surgical approaches for mild cases and surgical intervention for established contractures, with collagenase clostridium histolyticum (CCH) injection showing 70% success rates as a less invasive alternative to fasciectomy. 1, 2
Assessment
- Evaluate the degree of contracture by measuring passive extension deficit at metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints 2
- Identify palpable cords on the palmar surface of the hand 2
- Assess functional limitations in hand activities 1
- Document presence of nodules and their location 3
- Determine if contracture is ≥25° as this is predictive of recurrence after treatment 2
Non-Surgical Treatment Options
- Daily static stretching exercises when pain and stiffness are minimal 1
- Apply superficial moist heat before exercises to improve effectiveness 1
- Maintain terminal stretch position for 10-30 seconds before slowly returning to rest position 1
- Use resting hand/wrist splints combined with regular stretching 1
- Consider ultrasound-guided needle aponeurotomy combined with manual manipulation for less severe cases 4
Minimally Invasive Procedures
- Collagenase Clostridium Histolyticum (CCH) injection:
- Indicated for adults with palpable cords 2
- Success rate of approximately 70% with 25% recurrence rate 2
- More effective for MCP joints (80% success) than PIP joints (39% success) 5
- Requires no suture removal and allows for faster recovery 2
- Can be repeated for recurrent contractures with 75% success rate 2
- Needle aponeurotomy:
Surgical Treatment
- Limited fasciectomy:
Treatment Algorithm
For mild contractures (<25°) with minimal functional impairment:
For moderate contractures (25-45°) affecting function:
For severe contractures (>45°) or those not responding to minimally invasive approaches:
Follow-up and Monitoring
- Assess treatment success by measuring contracture reduction to ≤5° 5
- Monitor for recurrence, particularly in patients with pre-treatment contractures ≥25° 2
- Evaluate hand function and patient satisfaction after treatment 5
- Consider repeat CCH injections for recurrent contractures 2
Common Pitfalls and Caveats
- Distinguish Dupuytren's contracture from contractures caused by neurological conditions 1
- PIP joint contractures are more resistant to treatment than MCP joint contractures 5
- Patients should be counseled about potential recurrence rates with all treatment modalities 2, 3
- Consider patient factors such as recovery time needs and functional demands when selecting treatment approach 2